-
effectivehealthcare.ahrq.gov/health-topics/mastectomy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Clinical Presentation Brain Cancer Diagnosis from Usual Care Screening Brain Cancer Diagnosis from MCST Breast … Cancer Unknown Diagnosis Method Breast Cancer Diagnosis from Clinical Presentation Breast Cancer Diagnosis … from Usual Care Screening Breast Cancer Diagnosis from MCST Cervical Cancer Unknown Diagnosis Method … targeted by LZH8 aptamer sequence [LZH8; liver cancer], human epidermal growth factor receptor 2 [HER2; breast … cancer], prostate-specific antigen [PSA; prostate cancer], cancer antigen 125 [CA125; ovarian cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Clinical Presentation Brain Cancer Diagnosis From Usual Care Screening Brain Cancer Diagnosis From MCST Breast … Cancer Unknown Diagnosis Method Breast Cancer Diagnosis From Clinical Presentation Breast Cancer Diagnosis … From Usual Care Screening Breast Cancer Diagnosis From MCST Cervical Cancer Unknown Diagnosis Method … targeted by LZH8 aptamer sequence [LZH8; liver cancer], human epidermal growth factor receptor 2 [HER2; breast … cancer], prostate-specific antigen [PSA; prostate cancer], cancer antigen 125 [CA125; ovarian cancer
-
effectivehealthcare.ahrq.gov/products/dcis-endocrine-therapy/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-275-people-with-disabilities-disposition-comments.pdf
September 16, 2024 - Peer Reviewer
#1
Results Table 9: Lack of sedation during breast cancer
screening? … In the relevant text, it is noted that, in general, the RCTs that
studied breast cancer screening and … For breast cancer screening and/or cervical cancer
screening, we have noted that RCTs generally found … For breast cancer screening
and/or cervical cancer screening, we have noted that RCTs
generally found … Alternatively,
elsewhere (e.g., section 3.2.2.2.1 Physical Disability)
you refer to “breast cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - cancer] [Russian]. … cancer] [Russian]. … [Treatment of disseminated breast cancer
with combined irradiation of the hypophysis by protons and … Neutron versus photon
radiotherapy for local control in inoperable breast cancer. … loss,
↓psychomotor
performance,
temporal muscle
fibrosis, brain
ulceration, optic
neuropathy, breast
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
November 01, 2009 - Layout 1
Background
Radiotherapy with charged particles can
potentially deliver maximal doses while
minimizing irradiation of surrounding
tissues. It may be more effective or less
harmful than other forms of radiotherapy
for some cancers. Currently, seven centers
in the United States have facilities for
particle (pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
September 01, 2014 - Breast Cancer
Eight new observational studies that assessed the
association between 25(OH)D and breast … One new observational study that assessed the
association between 25(OH)D and breast cancer-specific … The NHANES III analysis
reported a significant decrease in breast cancer mortality
during 9 years of … Breast Cancer
Only the B-rated WHI trial evaluated breast cancer. … It
reported no significant reduction in breast cancer incidence
or mortality with combined vitamin
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
June 09, 2021 - cancer, or melanoma is frankly
naïve and limits the value of the evidence
summary. … In KQ1b, only one study
evaluated breast cancer brain
metastases only. … While there did
appear to be a difference in
deaths due to brain metastases,
this breast cancer subgroup … cancer patient only. … Cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
October 15, 2024 - cancer as an outcome. … estrogen plus
progestin was associated with an increased risk of conditions such as heart disease, breast … cancer,
and stroke and blood clots, as well as gallbladder disease. … cancer. … A
priori subgroups of interest for all KQs include type of menopause, underlying risk for breast
cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
October 15, 2024 - cancer as an outcome. … estrogen plus
progestin was associated with an increased risk of conditions such as heart disease, breast … cancer,
and stroke and blood clots, as well as gallbladder disease. … cancer. … A
priori subgroups of interest for all KQs include type of menopause, underlying risk for breast
cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - Not all common malignancies were well-represented
in this study (e.g., breast cancer), and further evaluation
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-different-models-of-survivorship-care-and-sets-of-services-on-late-and-long-term-net-health-outcomes-eg-for-breast-cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
August 27, 2012 - Slide 17
Maximum Acceptable Breast-Cancer Risk
Vasomotor Symptoms
Image: Bar chart with 3 sets … Slide 18
Maximum Acceptable Breast-Cancer Risk
Vasomotor Symptoms
Image: Bar chart with 3 sets
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Implications of
Multigene Panels for Hereditary Breast
Cancer Risk Assessment. … Network (CISNET),
Breast Cancer Surveillance Consortium
(BCSC). … Breast Cancer Screening Strategies. … Implications of
Multigene Panels for Hereditary Breast
Cancer Risk Assessment. … Imaging
Techniques for Treatment Evaluation for
Metastatic Breast Cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/web-based_dubenske_presenter.pdf
January 01, 2009 - DuBenske_Presentation_REVISED_FINAL
Source:
Eisenberg
Center
Conference
Series
2009,
Translating
Information
Into
Action:
Improving
Quality
of
Care
Through
Interactive
Media,
Effective
Health
Care
Program
Web
site
(http://www.effectivehe…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - adults.
37 Peer Reviewer 3 Methods For the most part yes unclear why for the subset
analysis for breast … cancer for the WHI study was not
included
We have added the post hoc analysis for breast
and colorectal … cancer
and trend for reduced risk for colorectal cancer. … We have added the data and a discussion of the
hip fracture, colorectal cancer, and breast
cancer findings … cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - 26, all
histologies
89Sr with dendritic
cell vaccine
40 0 NR NR 58% at 36 mo
Yamada,
201214
16, breast … cancer
89Sr and zoledronic
acid
88 31 NR NR NR
Zorga, 201126 49, all
histologies
89Sr 77 NR Hemotoxicity … Concurrent use of Sr-89
chloride with zoledronic acid is safe and effective for breast cancer
patients … Bone-related complications
and quality of life in advanced breast cancer: Results from a
randomized phase … cancer: A randomized, double-blind study.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
January 22, 2010 - Predictors of pessimistic breast cancer risk
perceptions in a primary care population. … Black-white differences in risk perceptions of breast cancer
survival and screening mammography benefit … Latina patient perspectives about informed treatment
decision making for breast cancer. … Retention and use of breast cancer recurrence risk
information from genomic tests: the role of health … Agreement between scales in the measurement of
breast cancer risk perceptions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - • Deleterious BRCA gene mutations (breast cancer)
• Lynch syndrome or presence of deleterious mismatch … Recommendations on screening for breast
cancer in average-risk women aged 40-74 years. … BRCA in breast cancer: ESMO Clinical Practice
Guidelines. … Practice bulletin no. 122: Breast cancer screening.